Grosses Analysis: Farinelli and the King Kicks Off 2018 With Strong Box Office

Grosses   Grosses Analysis: Farinelli and the King Kicks Off 2018 With Strong Box Office
 
The Mark Rylance-led play had its second highest-grossing week at the box office.
Farinelli_and_the_King_Broadway_Production_Photo_2017_Crane Rylance Farinelli (c) Joan Marcus 0122_HR.jpg
Sam Crane and Mark Rylance Joan Marcus

The Broadway transfer of Claire van Kampen’s hit London play Farinelli and the King, starring Tony and Academy Award winner Mark Rylance, is off to a healthy 2018.

Despite a blizzard that brought much of the York City metro area to a standstill on January 4, Farinelli and the King reported its second-highest box office take, earning $814,072 for the week ending January 7.

Get an in-depth look at this past week's grosses here.

The production was top earner among Broadway’s eight currently running plays, beating out the Uma Thurman-led Parisian Woman by more than $100,000 for a full eight-performance week.

Farinelli’s lead was due in part by an unexpected cancellation at Meteor Shower on January 7 after both Amy Schumer and Laura Benanti were sidelined due to illness, reducing it to seven performances rather than its regularly-scheduled eight-show week.

Year over year Broadway is ahead in its first full week of 2018, surpassing last year’s take of $29,567,891 by $2.6 million, coming in at $32,207,507 for the first full week of January.

With the exception of the Bette Midler revival of Hello, Dolly!, which began performances in March of last year, each of Broadway’s top-earning shows surpassed last year’s figures, including Hamilton at $3,132,598 over $2,456,491; The Lion King at $2,622,799 over $2,045,683; Wicked at $1,926,621 over $1,845,325; and Dear Evan Hansen at $1,744,820 over $1,065,347. Midler brought in $2,206,170 for her penultimate week in Dolly! at the Shubert Theatre.

Click Here to Shop for Theatre
Merchandise in the Playbill Store
 
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!